Cargando…

Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report

Colorectal squamous cell carcinoma (SCC) is extremely rare and associated with a poor prognosis. And the pMMR/MSS colorectal cancer is related to a limited response to programmed death ligand-1 (PD-1) blockade monotherapy. However, the clinical activity of PD-1 blockade monotherapy or combination th...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yanxin, Wang, Lunqing, Li, Xiao, Zhang, Tongsong, Song, Tingting, Zhang, Junling, Yu, Yangyang, Chen, Shiqing, Song, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185331/ https://www.ncbi.nlm.nih.gov/pubmed/34113555 http://dx.doi.org/10.3389/fonc.2021.596342

Ejemplares similares

Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer
por: Lin, Haishan, et al.
Publicado: (2022)

Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade
por: Liu, Xiaoliang, et al.
Publicado: (2019)

Squamous cell carcinoma of ascending colon with pMMR/MSS showed a partial response to PD-1 blockade combined with chemotherapy: A case report
por: Liu, Yan, et al.
Publicado: (2023)

Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer
por: Wang, Ting, et al.
Publicado: (2023)

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report
por: Yang, Jiabao, et al.
Publicado: (2023)

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report
por: Zhong, Liting, et al.
Publicado: (2022)

Immunotherapy combined with local therapy in the late-line treatment of repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer
por: Ding, Yuwei, et al.
Publicado: (2023)

Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report
por: Cheng, Xianshuo, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
por: Marmorino, Federica, et al.
Publicado: (2020)

Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria
por: Sun, Ci-Yuan, et al.
Publicado: (2020)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China
por: Gou, Miaomiao, et al.
Publicado: (2022)

A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX
por: Zhu, Jiangpeng, et al.
Publicado: (2023)

Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4(+) T Cells in the Central Region of pMMR CRC
por: Qi, Jingwen, et al.
Publicado: (2021)

Leiomyosarcoma of the rectosigmoid junction, a case report
por: Avendano, Tania Lisseth Mercado, et al.
Publicado: (2020)

MiR-6511b-5p suppresses metastasis of pMMR colorectal cancer through methylation of CD44 by directly targeting BRG1
por: Sun, JinMing, et al.
Publicado: (2022)

Robotic surgery for rectosigmoid junction tumor with ovarian metastases
por: Bedirli, Abdulkadir, et al.
Publicado: (2015)

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
por: Kelkar, Sneha S., et al.
Publicado: (2022)

Rectal NETs and rectosigmoid junction NETs may need to be treated differently
por: Cai, Wen, et al.
Publicado: (2019)

Gaelic Medical Mss. and Their Authors
por: Mackinnon, Donald
Publicado: (1895)

Gaelic Medical Mss. and Their Authors
por: Mackinnon, Donald
Publicado: (1895)

Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer
por: Zhu, Qiuwei, et al.
Publicado: (2023)

PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells
por: Gutting, Tobias, et al.
Publicado: (2021)

Paraneoplastic pyoderma gangrenosum associated with adenocarcinoma of the rectosigmoid junction: a case report
por: Alassani, Fousséni, et al.
Publicado: (2019)

Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction
por: Vieira, Lucas Maciel, et al.
Publicado: (2021)

Case Report: Genetic and immune microenvironmental characteristics of a rectal cancer patient with MSS/PD-L1-negative recurrent hepatopulmonary metastasis who achieved complete remission after treatment with PD-1 inhibitor
por: Song, Yang, et al.
Publicado: (2023)

Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors
por: Zhang, Yan, et al.
Publicado: (2022)

Schwannoma of the Rectosigmoid Colon
por: Mokhtari, Maral, et al.
Publicado: (2022)

Diffuse Large B Cell Lymphoma of the Rectosigmoid Junction: Case Report and Literature Review
por: Khorgami, Zhamak, et al.
Publicado: (2013)

A postsurgical prognostic nomogram for patients with lymph node positive rectosigmoid junction adenocarcinoma
por: Yanlong, Wu, et al.
Publicado: (2023)

Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors?
por: Lin, Andy Yingjie, et al.
Publicado: (2015)

Chemically Induced Oncogenesis in the Peripheral Nervous System Is Suppressed in Congenic BDIX.BDIV-Mss1 and -Mss7 Rats
por: Koelsch, Bernd, et al.
Publicado: (2015)

Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway
por: Xu, Xinjian, et al.
Publicado: (2020)

Acute Spontaneous Perforation of Rectosigmoid Junction in a Patient with Quadriplegia following Spinal Cord Injury
por: Basnayake, Oshan, et al.
Publicado: (2020)

Three English Medical MSS., 1550-1660
por: Young, John
Publicado: (1900)

Is Rectosigmoid Vaginoplasty Still Useful?
por: Kim, Seok-Kwun, et al.
Publicado: (2017)

Not a Common Rectosigmoid Perforation
por: Ishtiaq, Rizwan, et al.
Publicado: (2017)

Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects
por: Suarez-Carmona, Meggy, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitors in Proficient Mismatch Repair (pMMR)/ Non-Microsatellite Instability-High (non-MSI-H) metastatic colorectal cancer: a study based on 39 cohorts incorporating 1723 patients
por: Wu, Qing, et al.
Publicado: (2023)

Does PD-1 blockade play a decisive role in the pathological complete remission of unresectable MSS, BRAF V600E-mutated metastatic colorectal cancer: A case report
por: Tan, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p1jvo6ou1i1jgm2t2q36cv4ufn